Related Experiment Videos

[Acute lymphoblastic leukemia: treatment results in 27 children (author's transl)]

J L Bezanilla Regato, T González Casaseca

    Anales Espanoles De Pediatria
    |June 1, 1976
    PubMed

    Insights

    This study on childhood acute lymphoblastic leukemia achieved an 88% remission rate. Prophylaxis with intrathecal Methotrexate significantly reduced leukemic meningitis, though infection remained a leading cause of mortality.

    Area of Science:

    • Pediatric Oncology
    • Hematology
    • Leukemia Research

    Context:

    • Acute lymphoblastic leukemia (ALL) is a significant childhood cancer.
    • Effective treatment protocols are crucial for improving outcomes.
    • Managing complications like leukemic meningitis is a key challenge.

    Purpose:

    • To describe the therapeutic protocol and treatment outcomes for pediatric acute lymphoblastic leukemia.
    • To evaluate the efficacy of intrathecal Methotrexate for preventing leukemic meningitis.
    • To identify the primary causes of mortality in this cohort.

    Summary:

    • Twenty-seven children with acute lymphoblastic leukemia (ALL) were treated. An 88% remission rate was achieved.
    • Intrathecal Methotrexate prophylaxis for leukemic meningitis was highly effective, with only one case developing.
    • Survival rates were 35% for those followed for two or more years. Infection was the most frequent cause of death.

    Impact:

    • Demonstrates the effectiveness of a specific therapeutic protocol for pediatric ALL.
    • Highlights the success of intrathecal Methotrexate in preventing leukemic meningitis.
    • Provides insights into mortality factors, guiding future research and clinical practice in pediatric leukemia treatment.

    Related Concept Videos